You are here

Article Text

Article menu
Download PDFPDF
Phenotypes
Short Report
Chitayat-Hall and Schaaf-Yang syndromes:a common aetiology: expanding the phenotype of MAGEL2-related disorders
  1. Rebekah Jobling1,2,
  2. Dimitri James Stavropoulos1,3,
  3. Christian R Marshall1,4,
  4. Cheryl Cytrynbaum2,
  5. Michelle M Axford1,
  6. Vanessa Londero1,
  7. Sharon Moalem5,
  8. Jennifer Orr1,
  9. Francis Rossignol6,7,
  10. Fatima Daniela Lopes6,8,9,
  11. Julie Gauthier6,
  12. Nathalie Alos6,7,
  13. Rosemarie Rupps10,
  14. Margaret McKinnon10,
  15. Shelin Adam10,
  16. Malgorzata J M Nowaczyk11,
  17. Susan Walker4,12,
  18. Stephen W Scherer4,12,13,
  19. Christina Nassif6,7,
  20. Fadi F Hamdan6,7,
  21. Cheri L Deal6,7,
  22. Jean-François Soucy6,7,
  23. Rosanna Weksberg2,
  24. Patrick Macleod14,
  25. Jacques L Michaud6,7,
  26. David Chitayat2,15
  1. 1 Genome Diagnostics, Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
  2. 2 Division of Clinical Genetics and Metabolism, Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada
  3. 3 Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
  4. 4 The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, Canada
  5. 5 Regenoron, New York City, New York, USA
  6. 6 CHU Sainte-Justine, Montréal, Quebec, Canada
  7. 7 Department of Pediatrics, Université de Montréal, Montréal, Quebec, Canada
  8. 8 Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal
  9. 9 ICVS/3B’s - PT Government Associate Laboratory, Guimarães, Portugal
  10. 10 Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada
  11. 11 Division of Clinical Pathology, McMaster University, Hamilton, Ontario, Canada
  12. 12 Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada
  13. 13 Department of Molecular Genetics and McLaughlin Centre, University of Toronto, Toronto, Ontario, Canada
  14. 14 The Centre for Biomedical Research, University of Victoria, Victoria, British Columbia, Canada
  15. 15 The Prenatal Diagnosis and Medical Genetics Program, Department of Obstetrics and Gynecology, Mount Sinai Hospital, New York City, New York, USA
  1. Correspondence to Dr David Chitayat, Division of Clinical Genetics and Metabolism, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada; David.Chitayat{at}sinaihealthsystem.ca

Abstract

Background Chitayat-Hall syndrome, initially described in 1990, is a rare condition characterised by distal arthrogryposis, intellectual disability, dysmorphic features and hypopituitarism, in particular growth hormone deficiency. The genetic aetiology has not been identified.

Methods and results We identified three unrelated families with a total of six affected patients with the clinical manifestations of Chitayat-Hall syndrome. Through whole exome or whole genome sequencing, pathogenic variants in the MAGEL2 gene were identified in all affected patients. All disease-causing sequence variants detected are predicted to result in a truncated protein, including one complex variant that comprised a deletion and inversion.

Conclusions Chitayat-Hall syndrome is caused by pathogenic variants in MAGEL2 and shares a common aetiology with the recently described Schaaf-Yang syndrome. The phenotype of MAGEL2-related disorders is expanded to include growth hormone deficiency as an important and treatable complication.

  • growth hormone deficiency
  • magel2
  • schaaf-yang syndrome
  • chitayat-hall syndrome
  • genetics

https://doi.org/10.1136/jmedgenet-2017-105222

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • JLM and DC contributed equally.

    • Contributors CC, SM, FR, NA, RR, MM, SA, MJMN, CLD, RW, PM and DC performed clinical assessment and provided phenotypic information regarding the patients. FR, FDL, JG, FFH, CN, J-FS, JLM, RJ, DJS, CRM, SWS, JO and SW provided sequencing, data analysis, interpretation and validation of variants. RJ, VL and MMA performed phasing experiments for the variant in family 3. The manuscript was drafted by RJ, FR, DC and JLM. All authors provided critical revision of the article.

    • Funding The McLaughlin Centre, University of Toronto, Toronto, Canada, and Fondation Jeanne et Jean- Louis Lévesque (JLM). The Centre for Genetic Medicine, The Hospital for Sick Children, Toronto, Canada. FDL has a fellowship funded by FCT - Fundação para a Ciência e a Tecnologia (SFRH/BD/84650/2010).

    • Competing interests None declared.

    • Patient consent Parental/guardian consent obtained.

    • Ethics approval The Hospital for Sick Children, Toronto, Canada, and Centre hospitalier universitaire Sainte-Justine.

    • Provenance and peer review Not commissioned; externally peer reviewed.